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An Innovative
Application to Increase
Adherence to Treatment
Through Self-monitoring
for Patients With CKD
and Provide Information
for the General PopulationTo the Editor: A growing global public health prob-
lem in recent years is chronic kidney disease (CKD),
due to its increasing prevalence. Approximately 10%
of the general global population currently suffers from
CDK.1–3 In Brazil, approximately 126,583 patients un-
derwent dialysis in 2017,4 and a total of 5929 kidney
transplantations were performed in 2017.5
CKD treatment, especially dialysis, is recognized for
the high demand in care. Adherence to therapy and
control of all associated comorbidities is a difﬁcult task
for both patients and caregivers. The complex disease
context requires a high level of patient involvement
and self-care skills.6 Improving patient education and
awareness is one of the most effective strategies to in-
crease adherence to treatment, although an ideal level
of adherence is yet to be realized even in industrialized
countries.7–9
The use of technology for health promotion, more
speciﬁcally the personalized care proposed by the
mHealth ﬁeld (mobile health), offers new opportunities
for supporting preventive care and monitoring diseases
with the possibility to customize to individual needs.
In many societies, public access to technology has been609
Table 1. Functionalities of the Renal Health application
Public Functionalities Explanation
General population Information
Tests
About kidneys:
What are the kidneys
Which are the main
functions of the kidneys
What is chronic kidney
disease (CKD)
Main causes
Main symptoms
Treatment
How to prevent CKD
Frequent doubts
No examinations:
Hydration test
Questionnaire of CKD risk
With examinations:
Calculator of glomerular
ﬁltration rate
Hemodialysis patient Treatment
Agenda
Informations
Nutritional Table
Fluid control
Weight control
Examinations
History
Medications
Examinations
Medical appointments
General
About treatment
Stay tuned
Amount of phosphorus in food
Amount of potassium in food
Amount of sodium in food
Kidney transplantation
patients
History
Agenda
Information
Creatinine
Blood pressure
Blood glucose
Weight
Medications
Examinations
Medical appointments
Stay tuned:
Signs and symptoms of
infection and rejection
Recommendations:
About medication
General
Nutritional
Frequent doubts
RESEARCH LETTERSdemocratized and is present across the different social
classes. According to data from the National Household
Sample Survey conducted in Brazil, in 2015, approxi-
mately 102.1 million Brazilian inhabitants, aged 10
years or older, accessed the Internet during the survey
reference period.10We report thedesign anddevelopment
of an innovative health application for patients with CKD
available on cellular phones, with information and ser-
vices to support their treatment through self-monitoring,
as well as information about kidney diseases and its ways
of prevention for the general population.
The proposed tool is an application for use on mobile
devices, which we have called “Renal Health,” initially
designed for the Android platform, in Portuguese, with
free access (already available at the Google Play
store: https://play.google.com/store/apps/details?
id¼br.unifor.renalhealth), and a Web-based admin-
istration tool, built on the JAVA platform. The brand
“Renal Health” was registered and linked to this
application in Brazil. This application was developed
within the activities of the “Renal Health Project,” a
multidisciplinary project from the University of
Fortaleza, northeast of Brazil, in partnership with
other universities and supported by the International
Society of Nephrology, through its Clinical Research
Program (approved in the 2017 call).
Initially we have identiﬁed the requirements11 based
on the target population and patients’ responses during
the interviews and the researchers’ experience, and the
basic needs, established during the meetings together
with the information technology team, which would
meet the assessed requirements, such as: information
on CKD and treatment, calculation of the glomerular
ﬁltration rate, weight-management calculators, nutri-
tional guidelines, and medication and consultation day
alerts, among others. The complete requirement’s list is
available on request.
After establishing the requirements, deﬁning the
functionalities that would be developed, the ﬁrst screen
interfaces that comprise the application were drawn and
widely discussed in meetings with the multidisciplinary
team. Based on the prototypes generated in the previous
stage of the technological artifact design and develop-
ment, the interactive version of the Renal Health appli-
cation was developed with several functionalities for
individuals without a CKD diagnosis and patients with
CKD undergoing renal replacement therapy, in the
hemodialysis and transplantation modalities, as summa-
rized in Table 1.
For individuals without a CKD diagnosis, sessions
were developed with contents on disease deﬁnition,
signs and symptoms, preventive measures, causes,
treatment, and frequently asked questions, as well as a
risk stratiﬁcation questionnaire and glomerular610ﬁltration rate calculator. Functionalities were devel-
oped to help patients self-monitor their hemodialysis
and kidney transplant treatments, In relation to medi-
cation needs, for example, dialysis patients generally
need a large number of pills each day12 and non-
adherence to drug therapy is a common problem among
renal transplantation patients.13,14 Therefore, due to
the frequent occurrence of this attitude and its
important effects on prognosis, strategies to stimulate
adherence, such as usage of the Renal Health applica-
tion, need to be implemented. Researchers have
concluded that the main strategies for drug therapy
adherence among renal transplant recipients were pill
counting, reminders, and alarms.15 To reach the ﬁnal
version of the application, we have conducted an
interactive process, with researchers, patients, and
health care providers in the ﬁeld of nephrology,
through which we have discussed patients’ needs,Kidney International Reports (2019) 4, 603–613
Table 3. Results of the tests of the Renal Health application with
specialists (health care providers)
Tasksa Mean index
Language is compatible with patients 1
Information/Contents are adequate 0.83
Functionalities are adequate 1
The application can promote behavioral changes regarding
adherence to treatment
1
The application can be publicized to the nephrology community 0.83
The content is motivating and encourages patients to navigate in
the application
1
The application is adequate to guide patients and the general
population regarding chronic kidney disease
0.83
The scientiﬁc information presented is correct 1
The material is appropriate regarding sociocultural aspects of the
population
1
The content and messages are attractive 1
The illustrations (images) are adequate 1
The colors are adequate 0.83
The size of the fonts is adequate 0.66
The amount of information is adequate 1
The material presents the necessary contents regarding chronic
kidney disease
1
The material presents the necessary contents regarding
hemodialysis
0.83
The material presents the necessary contents regarding kidney
transplantation
1
The material is adequate to help health care providers to educate
their patients
0.83
aContent Validity Index.16
Table 2. Patients’ responses to the tasks asked during the usability
test of the Renal Health application
Very hard Hard Normal
Easy/very
easy
 Level of difﬁculty to login to the
application
2 2 6
 Level of difﬁculty to register information
regarding the amount of water you can
drink per day
6 4
 Level of difﬁculty to change the daily limit
of water amount you can drink per day
1 2 7
 Level of difﬁculty to calculate your weight 1 1 5 3
 Level of difﬁculty to register a laboratory
test result
1 7 2
 Level of difﬁculty to search for information
about your last 2 registered body weights
5 1 4
RESEARCH LETTERSpresented a preliminary version of the applications,
and then proceeded to the suggested modiﬁcations to
get to the ﬁnal version of the application that was
launched in the virtual stores. Detailed information
about the creation process of the Renal Health appli-
cation is available in the supplementary material.
The usability test of the application was performed
with patients and health care providers, and it is a
different test for patients and professionals. Although
patients are asked to use the application, performing
some tasks, health care providers are asked to evaluate
the functionalities of the application and give their
opinion about the adequacy for patients regarding its
contents, its language, and so forth. The ﬁrst system
usability test was conducted with 10 patients with
CKD, aged between 19 and 47 years (mean 32 years,
SD ¼ 10.2). Of these patients, 4 were college graduates,
2 were high school graduates, 2 had not ﬁnished high
school, and 2 had not ﬁnished elementary school.
Before beginning the test, all participants signed the
free and informed consent form. The test consisted of
performing 7 tasks that have greater relevance in the
application. Soon after the evaluation, the users were
asked to complete a form with their impressions about
the software and questions about the degree of difﬁ-
culty when performing the respective tasks in the
application. Most patients classiﬁed the questions as
“normal,” “easy,” and “very easy.” Table 2 summa-
rizes the responses of the tasks that patients were asked
to complete during the usability test of the application.
The test with specialists in nephrology was per-
formed in the computer laboratory of University of
Fortaleza. Six professionals attended the test, including
a nutritionist, psychologist, 2 nurses, and 2 nephrolo-
gists, all working in the respective ﬁeld for more than 5
years. After the presentation, guests were asked to log
in to conduct the evaluation and to complete a form
regarding the objectives, structure, functionality, and
relevance of the application. The specialists madeKidney International Reports (2019) 4, 603–613comments and suggestions that were useful for the
evaluation of qualitative analyses. Of all the application
assessments, only 3 showed a Content Validity Index
below the threshold level of 0.78, and those were
related to the font size, text size reduction, and content
adequacies to improve users’ understanding. All the
other items had a higher Content Validity Index, which
is considered high.16 The positive approval percentage
was 89.6%. The results of the tests with specialists are
summarized in Table 3. The main screens of the Renal
Health application can be seen in the supplementary
material (Supplementary Figure S1).
Besides the innovative character of the tool, our
study was conducted in a multidisciplinary approach,
with a team of professionals from diverse ﬁelds
involved in the designing of the application. The
development of mHealth applications, such as Renal
Health, represents a new approach for health care
systems, as they face difﬁculties regarding resource
scarcity, health management, and the growing de-
mands of patients with chronic conditions in low- and
middle-income countries. According to Levine et al.,17
mHealth applications can solve the disparities in access
to health services and shortage of human resources,
along with inadequacies of health care infrastructure
and limitations in ﬁnancing. Future studies are needed
to investigate the clinical outcomes of hemodialysis
patients and renal transplant recipients continuously611
RESEARCH LETTERSusing the Renal Health application and to explore
whether using this technology is associated with a
reduction in CKD treatment problems and its associated
complications. We will conduct a study to investigate
if use of this application increases patients’ adherence
to treatment and consequently decreases complications
(in patients on hemodialysis and after renal trans-
plantation). By now we have information that hun-
dreds of patients have already downloaded the
application in all the regions of Brazil.
In summary, the ﬁrst version of the Renal Health
application was assessed positively by patients with
CKD and by experienced professionals in the area.
The need for some application modiﬁcations was
identiﬁed, aimed at improving it by making it easier
to use. These modiﬁcations have been incorporated
into the latest versions. Technological advancements
offer opportunities for screening new cases of CKD in
the general public, achieving early diagnosis and
periodic follow-up of patients with underlying dis-
eases. We believe that using the Renal Health appli-
cation can be an important tool for providing
knowledge on CKD control not only to patients with
CKD, health care professionals, family members, and
caregivers of patients with CKD, but also to the
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